PROTAGENIC THERAPEUTICS, INC.
Protagenic Therapeutics, Inc. is a pre-clinical biopharmaceutical company endeavoring to develop first-in-class neuro-active peptides into human therapeutics to treat several stress related disorders. Protagenic Therapeutics is building a TCAP platform to address many neuropsychiatric disorders and other neurodegenerative diseases that are impacted by the stress response system of the brain.
Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.